Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026)

Boston Scientific's Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 26.88% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (up 26.88% YoY), while the FY2025 annual figure was $2.4 billion, up 28.61% from the prior year.
• Other Non-Current Liabilities came in at $2.5 billion for Q1 2026 at Boston Scientific, up from $2.4 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 billion in Q1 2026 to a low of $1.8 billion in Q2 2024.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities dropped 16.55% in 2022 and jumped 32.39% in 2025, its largest moves.
• Boston Scientific's Other Non-Current Liabilities stood at $2.0 billion in 2022, then dropped by 3.34% to $2.0 billion in 2023, then retreated by 4.93% to $1.9 billion in 2024, then advanced by 28.61% to $2.4 billion in 2025, then climbed by 2.66% to $2.5 billion in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $2.5 billion, $2.4 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison